Dr. Jesse J. Keller, MD

Dr. Keller practices at OHSU Hospital in Portland, Oregon, part of State of Oregon.

Dr. Keller's NPI, 1326334285, was assigned on June 20, 2011. Dr. Keller graduated from University of Washington School of Medicine in 2011. Dr. Keller holds Oregon license MD171570.

Dr. Keller's primary practice is OHSU Hospital, at 3181 SW Sam Jackson Park Road, Portland, OR 97239 in Multnomah County. The practice phone is (503) 494-9000.

Dr. Keller's primary practice is OHSU Hospital in Portland, Oregon, part of State of Oregon. The medical group on file is Oregon Health & Science University (OHSU). Dmand AI also links Dr. Keller to 1 more clinical lab and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Keller practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Keller's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Keller is licensed in Oregon.

CMS data shows 797 Medicare services from Dr. Keller across 12 procedure codes in 2024, for 373 Medicare patients. Medicare paid $30,045 for them.

CMS counts 373 Medicare patients who saw Dr. Keller in 2024. The largest group is 65 to 74, with 166 patients. 55% of them have high blood pressure, and 53% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Keller's median patient age at 73, with 44% women.

In 2024, Dr. Keller wrote 569 Medicare Part D claims for 106 patients. 91% of them were for generic drugs. CMS names the drug for 354 of them, across 15 drugs with 11 or more claims each, at $12,489 in total drug cost. In 2023, CMS named 343 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Keller for performance year 2024, reported through an alternative payment model (APM). Dr. Keller accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Keller as offering telehealth. CMS counts 164 procedures of removal of skin lesions by Dr. Keller, more than 78% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 19 papers to Dr. Keller, published from 2020 to 2025. 2020 was the busiest year, with 4. The most frequent topics are Skin, Pyoderma Gangrenosum and Skin Diseases. Dr. Keller has published most often in Arch Dermatol Res. Dr. Keller's most frequent co-authors are Robert Gil Micheletti, MD, Arturo Ricardo Dominguez, MD and Arash Mostaghimi, MD, MPA, MPH.

CMS Open Payments shows 14 general payments to Dr. Keller from 2 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 72% of the total. Galderma Laboratories, L.P. paid the most, $13,835.

Dr. Keller graduated from University of Washington School of Medicine in 2011.